Vasconcelos P,Luz-Rodrigues H,Santos C, et al. Desferrioxamine treatment of porphyria cutanea tarda in a patient with HIV and chronic renal failure [J]. Dermatol Ther,2014,27(1):16-18. ？ [2]Bartel D P. MicroRNAs:target recognition and regulatory functions[J]. Cell,2009,136(2):215-233.？ [3]Lujambio A,Lowe S W. The microcosmos of cancer[J]. Nature,2012,482(7385):347-355. ？ [4]Krutzfeldt J,Rajewsky N,Braich R, et al. Silencing of microRNAs ？in vivo？ with ‘antagomirs’[J]. Nature,2005,438(7068):685-689.？ [5]Tay Y,Rinn J,Pandolfi P P. The multilayered complexity of ceRNA crosstalk and competition[J]. Nature,2014,505(7483):344-352.？ [6]Geng L,Chaudhuri A,Talmon G, et al. MicroRNA-192 suppresses liver metastasis of colon cancer[J]. Oncogene,2014,33(46):5332-5340.？ [7]Kao C J,Martiniez A,Shi X B, et al. miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT[J]. Oncogene,2014,33(19): 2495-2503.？ [8]Szeto C C,Ching-Ha K B,Ka-Bik L, et al. Micro-RNA expression in the urinary sediment of patients with chronic kidney diseases[J]. Dis Markers,2012,33(3):137-144.？ [9]Chen J,Kam-Tao P,Kwan B C, et al. Relation between microRNA expression in peritoneal dialysis effluent and peritoneal transport characteristics [J]. Dis Markers,2012,33(1):35-42. [10]Neal C S,Michael M Z,Pimlott L K, et al. Circulating microRNA expression is reduced in chronic kidney disease[J]. Nephrol Dial Transplant,2011,26(11):3794-3802.？ [11]Wang H,Peng W,Ouyang X, et al. Reduced circulating miR-15b is correlated with phosphate metabolism in patients with end-stage renal disease on maintenance hemodialysis [J]. Renal Fail,2012,34(6):685-690.？ [12]Aguado-Fraile E,Ramos E,Conde E, et al. MicroRNAs in the kidney:novel biomarkers of acute kidney injury [J]. Nefrologia,2013,33(6):826-834.？ [13]Li B S,Zhao Y L,Guo G, et al. Plasma microRNAs,miR-223,miR-21 and miR-218,as novel potential biomarkers for gastric cancer detection[J]. PLoS One,2012,7(7):e41629.？ [14]Brase J C,Wuttig D,Kuner R, et al. Serum microRNAs as non-invasive biomarkers for cancer [J]. Mol Cancer,2010,9:306.？ [15]Li L M,Hu Z B,Zhou Z X, et al. Serum microRNA profiles serve as novel biomarkers for HBV infection and diagnosis of HBV-positive hepatocarcinoma[J]. Cancer Res,2010,70(23):9798-9807.？ [16]Kroh E M,Parkin R K,Mitchell P S, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) [J]. Methods,2010,50(4):298-301.？ [17]Luo Y,Wang C,Chen X, et al. Increased serum and urinary microRNAs in children with idiopathic nephrotic syndrome[J]. Clin Chem,2013,59(4):658-666.？ [18]Xiao B,Wang Y,Li W, et al. Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease[J]. Blood,2013,122(19): 3365-3375.？ [19]Nielsen L B,Wang C,Sorensen K, et al. Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls:evidence that miR-25 associates to residual beta-cell function and glycaemic control during disease progression [J]. Exp Diabetes Res,2012,2012:896362.？ [20]Mitchell P S,Parkin R K,Kroh E M, et al. Circulating microRNAs as stable blood-based markers for cancer detection[J]. Proc Natl Acad Sci U S A,2008,105(30):10513-10518. ？
